Wednesday, 28 October 2026European Markets

European Markets

5 articles

UK Gilt Yields Hit 5.10% as Starmer Rebellion Spreads Contagion to EU Markets

UK Gilt Yields Hit 5.10% as Starmer Rebellion Spreads Contagion to EU Markets

UK gilt yields surged to 5.10% in mid-May 2026, driving equity sell-offs across UK and European markets. Sterling's sharp decline against the euro reflects a crisis-of-confidence feedback loop as Starmer faces an 80+ MP rebellion and JPMorgan warns of a 3–5% banking surcharge. With Fed futures pricing only a 1-in-3 chance of a US rate cut in 2026, the higher-for-longer global rate backdrop leaves EU markets exposed.

LM Salvado•
Gold at $4,200/oz Drives EU Mining Expansions as UK Instability Fuels Safe-Haven Demand

Gold at $4,200/oz Drives EU Mining Expansions as UK Instability Fuels Safe-Haven Demand

Gold futures hit record $4,200/oz in November 2026 as UK political turmoil and tech sector losses drove European investors to precious metals. Mining firms across the EU region are accelerating expansion projects to capture elevated prices, with Fortuna Mining advancing Senegal's Diamba Sud and boosting production guidance 1-9% for 2026.

ViaNews Editorial Team (Europe)•
Euro Hits 20-Month High Against Pound as UK Budget Concerns Mount

Euro Hits 20-Month High Against Pound as UK Budget Concerns Mount

The British pound fell 0.4% to €1.13, its lowest level since April 2023, as currency markets anticipate further weakness ahead of the UK's November 26 budget. The euro's strength against sterling creates favorable conditions for European exporters and investors with UK exposure, while analysts forecast GBP could breach $1.30.

ViaNews Editorial Team (Europe)•
Euro Gains 14% Against Dollar as US Currency Hits Lowest Level Since 2022

Euro Gains 14% Against Dollar as US Currency Hits Lowest Level Since 2022

The euro has climbed 14% against the US dollar in 2025, while the British pound gained 7%, as the greenback fell to its lowest level since 2022. The currency realignment occurs amid upcoming Fed leadership changes and geopolitical shifts including US-Iran nuclear deal progress.

ViaNews Editorial Team (Europe)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com